Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DNHW41
|
|||
| Drug Name |
Collategene
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Peripheral Ischemic Ulcers [ICD-11: BD41] | Phase 2 | [1] | |
| Company |
AnGes USA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04267640) A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects Who Have Peripheral Ischemic Ulcers of the Lower Extremity. U.S.National Institutes of Health. | |||
| REF 2 | Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther. 2010 Sep;17(9):1152-61. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.